Bausch Health Companies Inc.
BHC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000885590
In the last 90 days, Bausch Health Companies Inc. insiders filed 0 open-market purchases and 1 sale; 219 institutions reported holding it in 13F filings for Q2 2026, worth $1.18B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Bausch Health Companies Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $258.9K in total
- Insiders trading
- 1
- Net value
- −$258.9K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Bausch Health Companies Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Lenar Aimee J. | President, US Pharma | 334,853 | Aug 20, 2026 | 4 |
| Lee Steven Hyosig | SVP, Controller & CAO | 70,114 | Jul 15, 2026 | 2 |
| Wechsler Amy B | Director | 314,979 | Jul 2, 2026 | 5 |
| Paulson John | Director | 430,242 | Jul 2, 2026 | 5 |
| Leung Sandra | Director | 97,070 | Jul 2, 2026 | 5 |
| Power Robert N | Director | 300,594 | May 26, 2026 | 1 |
| Garcia Christian A | Director | 135,578 | May 26, 2026 | 1 |
| Kavanagh Sarah B | Director | 282,230 | May 26, 2026 | 1 |
| Roberts Eiry | Director | 45,871 | May 26, 2026 | 1 |
| Goettler Michael | Director | 76,020 | May 26, 2026 | 1 |
| Lee Frank D. | Director | 95,210 | May 26, 2026 | 2 |
| Appio Thomas | Chief Executive Officer | 2,315,374 | Mar 3, 2026 | 3 |
| Charhon Jean-Jacques | EVP, CFO | 706,478 | Mar 3, 2026 | 2 |
| Carson Seana | EVP, General Counsel | 616,761 | Mar 3, 2026 | 3 |
| Paulson & Co. Inc. | 10% Owner | 73,255,869Indirect | Nov 28, 2025 | 1 |
| Icahn Brett | Director | 220,280 | Jul 2, 2025 | 0 |
| Mulligan Richard | Director | 155,616 | May 20, 2025 | 0 |
| Miller Steven D | Director | 229,224 | May 20, 2025 | 0 |
| Barresi John S | SVP, Controller & CAO | 192,268 | Mar 3, 2025 | 0 |
| Robertson Russel C | Director | 225,279 | Apr 1, 2024 | 0 |
| Vadaketh Tom George | EVP, Chief Financial Officer | 564,933 | Sep 6, 2023 | 0 |
| Ross Thomas W. Sr. | Director | 161,516 | May 19, 2023 | 0 |
| De Schutter Richard U | Director | 373,407 | Apr 4, 2023 | 0 |
| Karabelas Argeris N | Director | 123,715 | Jun 28, 2022 | 0 |
| Papa Joseph C | Director | 1,427,568 | May 12, 2022 | 0 |
| Spurr Robert | President, U.S. Businesses | 112,741 | May 12, 2022 | 0 |
| Munsch Frederick | SVP, Controller and CAO | 22,435 | May 5, 2022 | 0 |
| Ackermann Christina | EVP AND GENERAL COUNSEL | 162,240 | Mar 11, 2022 | 0 |
| Gordon Joseph F | Pres&Co-Head Bausch&Lomb/Int'l | 93,139 | Mar 10, 2022 | 0 |
| Eldessouky Sam | EVP & Chief Financial Officer | 119,455 | Mar 7, 2022 | 0 |
| Von Eschenbach Andrew C. | Director | 38,647 | Aug 9, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 (view filing)4:33 PM ET | Aug 19 | 1 day | Lenar Aimee J.President, US Pharma | SSaleCommon Shares, No Par Value | −36.8K | $7.03 | −$258.9K | −9.9%334.9K after | 10b5-1 |
| May 20, 2026 (view filing) | May 19 | 1 day | Lee Frank D.Director | SSaleCommon Shares, No Par Value | −24.5K | $5.43 | −$132.8K | −33.1%49.3K after | 10b5-1 |
| Mar 3, 2026 (view filing) | Mar 2-3 | 1 day | Carson SeanaEVP, General Counsel | SSaleCommon Shares, No Par Value | −11.3K | $5.78 | −$65.1K | −1.8%616.8K after | 2 lots10b5-1 |
| Feb 27, 2026 (view filing) | Feb 27 | Same day | Carson SeanaEVP, General Counsel | SSaleCommon Shares, No Par Value | −8.39K | $5.95 | −$49.9K | −1.0%809.3K after | 10b5-1 |
| Nov 28, 2025 (view filing) | Nov 25 | 3 days | Paulson & Co. Inc.10% Owner | PPurchaseCommon Stock, no par value | +2.50M | $6.25 | +$15.6M | +3.5%73.3M after | |
| Sep 8, 2025 (view filing) | Sep 8 | Same day | Carson SeanaEVP, General Counsel | SSaleCommon Shares, No Par Value | −13.4K | $7.31 | −$97.7K | −2.6%499.6K after | 10b5-1 |
| Aug 22, 2025 (view filing) | Aug 21 | 1 day | Lee Frank D.Director | SSaleCommon Shares, No Par Value | −15.9K | $7.66 | −$121.9K | −17.7%73.8K after | |
| Aug 14, 2025 (view filing) | Aug 14 | Same day | Paulson JohnDirector | PPurchaseCommon Stock, no par value | +34.7M | $9.00 | +$312.5M | +96.4%70.8M after | |
| Aug 13, 2025 (view filing) | Aug 11-13 | 2 days | Paulson JohnDirector | PPurchaseCommon Stock, no par value | +3.24M | $6.56 | +$21.3M | +9.9%36.0M after | 3 lots |
| Jun 17, 2025 (view filing) | Jun 13 | 4 days | Paulson JohnDirector | PPurchaseCommon Stock, no par value | +3.56M | $5.94 | +$21.2M | +12.2%32.8M after | |
| Jun 12, 2025 (view filing) | Jun 10-12 | 2 days | Paulson JohnDirector | PPurchaseCommon Stock, no par value | +2.79M | $5.27 | +$14.7M | +10.5%29.2M after | 3 lots |
| Dec 3, 2024 (view filing) | Dec 2 | 1 day | Carson SeanaEVP, General Counsel | SSaleCommon Shares, No Par Value | −440 | $8.35 | −$3.67K | −0.1%433.1K after | 10b5-1 |
| Sep 9, 2024 (view filing) | Sep 6 | 3 days | Carson SeanaEVP, General Counsel | SSaleCommon Shares, No Par Value | −13.4K | $6.21 | −$83.0K | −3.0%435.2K after | 10b5-1 |
| Mar 4, 2024 (view filing) | Mar 4 | Same day | Carson SeanaEVP, General Counsel | SSaleCommon Shares, No Par Value | −6.31K | $9.80 | −$61.9K | −1.2%499.9K after | 4 lots10b5-1 |
| Dec 5, 2023 (view filing) | Dec 5 | Same day | Carson SeanaEVP, General Counsel | SSaleCommon Shares, No Par Value | −220 | $7.38 | −$1.62K | −0.1%382.9K after | 10b5-1 |
| Nov 6, 2023 (view filing) | Nov 6 | Same day | Carson SeanaEVP, General Counsel | SSaleCommon Shares, No Par Value | −43 | $7.61 | −$327.23 | 0.0%384.8K after | 10b5-1 |
| Sep 6, 2023 (view filing) | Sep 6 | Same day | Carson SeanaEVP, General Counsel | SSaleCommon Shares, No Par Value | −6.68K | $8.28 | −$55.4K | −1.7%385.2K after | 10b5-1 |
| Mar 7, 2023 (view filing) | Mar 3-6 | 4 days | Carson SeanaEVP, General Counsel | SSaleCommon Shares, No Par Value | −1.27K | $9.27 | −$11.8K | −0.3%443.2K after | Amended2 lots |
| Mar 1, 2023 (view filing) | Feb 28 | 1 day | Carson SeanaEVP, General Counsel | SSaleCommon Shares, No Par Value | −292 | $9.32 | −$2.72K | −0.1%359.2K after | |
| Apr 15, 2022 (view filing) | Apr 14 | 1 day | Spurr RobertU.S. President-Pharma Business | SSaleCommon Shares, No Par Value | −1.59K | $22.19 | −$35.4K | −1.7%90.5K after | |
| Mar 16, 2022 (view filing) | Mar 15 | 1 day | Spurr RobertU.S. President-Pharma Business | SSaleCommon Shares, No Par Value | −4.85K | $22.20 | −$107.6K | −5.0%92.1K after | |
| Mar 10, 2022 (view filing) | Mar 8 | 2 days | Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l | SSaleCommon Shares, No Par Value | −3.89K | $21.76 | −$84.6K | −4.0%93.1K after | |
| Mar 4, 2022 (view filing) | Mar 2 | 2 days | Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l | SSaleCommon Shares, No Par Value | −11.1K | $23.37 | −$258.9K | −9.9%101.1K after | |
| Mar 4, 2022 (view filing) | Mar 2 | 2 days | Spurr RobertU.S. President-Pharma Business | SSaleCommon Shares, No Par Value | −1.59K | $23.37 | −$37.3K | −2.4%65.4K after | |
| Mar 2, 2022 (view filing) | Mar 1 | 1 day | Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l | SSaleCommon Shares, No Par Value | −6.34K | $23.82 | −$151.0K | −5.3%112.2K after | |
| Feb 17, 2022 (view filing) | Feb 15 | 2 days | Spurr RobertU.S. President-Pharma Business | SSaleCommon Shares, No Par Value | −3.25K | $25.02 | −$81.3K | −5.1%60.3K after | |
| Jan 20, 2022 (view filing) | Jan 18 | 2 days | Spurr RobertU.S. President-Pharma Business | SSaleCommon Shares, No Par Value | −3.25K | $26.63 | −$86.6K | −4.9%63.5K after | |
| Dec 2, 2021 (view filing) | Nov 30 | 2 days | Miller Steven DDirector | PPurchaseCommon Shares, No Par Value | +50.0K | $24.24 | +$1.21M | +463.8%60.8K after | |
| Dec 2, 2021 (view filing) | Nov 30 | 2 days | Miller Steven DDirector | PPurchaseCommon Shares, No Par Value | +10.0K | $24.17 | +$241.7K | New position10.0K after | |
| Aug 9, 2021 (view filing) | Aug 5 | 4 days | Von Eschenbach Andrew C.Director | PPurchaseCommon Shares, No Par Value | +1.40K | $25.94 | +$36.3K | +3.8%38.6K after | |
| Aug 6, 2021 (view filing) | Aug 4 | 2 days | De Schutter Richard UDirector | PPurchaseCommon Shares, No Par Value | +10.0K | $25.01 | +$250.1K | +3.3%317.1K after |